Meniere's Disease Drug Market - Industry Trendst
Meniere's
Disease Drug Market - Industry Trends and Forecast to 2026 with key players
like Otonomy Inc., WellSpring Pharmaceutical Corporation, Sound Pharmaceutical,
Jubilant Cadista, Auris Medical, Pfizer Inc, Sun Pharmaceutical Industries Ltd
Meniere's
Disease Drug Market By Type ( Classic, Vestibular and Bilateral),
Mechanism of Action (Antihistamines, Benzodiazepines, Antinausea, Diuretics,
Antibiotics, Steroids and Others), Drugs (Meclizine, Diazepam,
Prochlorperazine, Hydrochlorothiazide, Gentamicin, Dexamethasone and Others),
Devices (Hearing Aid, Meniett device), Treatment (Medications, Therapy or
Hearing Aids, Surgery), Route of Administration (Oral, Intravenous,
Intratympanic and Others), Distribution Channel (Online Pharmacy, Direct
Tenders, Retailers and Others), End-Users (Hospitals, Homecare, Specialty
Clinics, Others), Geography (North America, Europe, South America,
Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Market Analysis: Global Meniere's Disease Drug Market
Global Meniere's disease drug Market is expected to grow at a
substantial CAGR in the forecast period of 2021-2026. The report contains data
of the base year 2018 and historic year 2017. This rise in market value can be
attributed to the high prevalence of hearing disorders and the lack of any
approved treatment options. Rising investment in the research & development
of treatments for Meniere’s disease is expected to drive the market.
Download full sample report of
Meniere's Disease Drug Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-menieres-disease-drug-market
Market Definition: Global Meniere's
Disease Drug Market
Meniere’s disease is a disorder of inner-ear that typically
affects one ear, inner ear is responsible for hearing and balance. This condition
can cause vertigo, ringing in the ear (tinnitus), feeling of pressure in the
ear, specific type of dizziness in which patient feel like spinning, hearing
loss that comes and goes. This is a chronic condition and can lead to permanent
hearing loss but treatments and lifestyle changes can help to control the
symptoms.
According to the report of National Institute on Deafness and
Other Communication Disorders of America, the prevalence of Meniere’s disease
is high in America and around 615,000 Americans are suffering from Meniere’s
disease and the number of patients increasing every year. Massachusetts Eye and
Ear (An international center for treatment and research and a teaching hospital
of Harvard Medical School) reported that approximately 60,000 new cases of
Meniere’s disease are diagnosed annually.
Market Drivers
High prevalence of Meniere’s disease is driving the market
growth
Increasing awareness of this disorder is another important
factor for the market growth
Rising investment in the research & development for the
treatments for this disease is expected to drive the market growth
Government initiative to increase awareness is elevating the
market growth
Market Restraints
Lack of any approved drug or treatment option is restricting the
market growth
Low healthcare expenditure in developing regions also acts as a
market restraint
High cost of treatment for this disease can also hamper the
market growth
Segmentation: Global Meniere's
Disease Drug Market
By Type
·
Classic
·
Vestibular
·
Bilateral
By Mechanism of Action
·
Anti-Histamines
·
Benzodiazepines
·
Antinausea
·
Diuretics
·
Antibiotics
·
Steroids
·
Others
By Drugs Type
·
Meclizine
·
Diazepam
·
Prochlorperazine
·
Hydrochlorothiazide
·
Gentamicin
·
Dexamethasone
·
Others
By Devices type
·
Hearing
Aid
·
Meniett
device
By Treatment Type
·
Medications
·
Therapy
or Hearing Aids
·
Surgery
By Route of Administration
·
Oral
·
Intravenous
·
Intratympanic
·
Others
By Distribution Channel
·
Online
Pharmacy
·
Direct
Tenders
·
Retailers
·
Others
By End-Users
·
Hospitals
·
Homecare
·
Specialty
Clinics
·
Others
By Geography
·
North
America
·
U.S.
·
Canada
·
Mexico
·
Europe
·
Germany
·
Italy
·
U.K.
·
France
·
Spain
·
Netherlands
·
Belgium
·
Switzerland
·
Turkey
·
Russia
·
Rest
of Europe
·
Asia-Pacific
·
Japan
·
China
·
India
·
South
Korea
·
Australia
·
Singapore
·
Malaysia
·
Thailand
·
Indonesia
·
Philippines
·
Rest
of Asia Pacific
·
South
America
·
Brazil
·
Rest
of South America
·
Middle
East & Africa
·
South
Africa
·
Rest
of Middle East & Africa
Key Developments in the Market
In June 2019, Otonomy Inc. is developing Otividex drug for the
treatment of Meniere’s disease which is under Phase 3 clinical trial, in
November 2017 Otonomy Inc announced that the AVERTS-2 trial, conducted in
Europe, achieved its primary endpoint (p value = 0.029) and Otividex
demonstrated clinically significant treatment benefit for patients
In May 2018, FDA approved IDE study for the treatment of
Meniere’s disease and intractable vertigo. In this study simultaneously
labyrinthectomy and cochlear implantation can be done in unilateral Meniere's
disease which further assists in determining speech perception, localization
and quality of life outcomes
Competitive Analysis:
Global
Meniere’s disease drug market is highly fragmented and the major players
have used various strategies such as new product launches, expansions,
agreements, joint ventures, partnerships, acquisitions, and others to increase
their footprints in this market. The report includes market shares of Meniere’s
disease drug market for Global Europe, North America, Asia-Pacific, South
America and Middle East & Africa.
Key Market Players:
The key market players in the global Meniere’s disease drug
market are Abbott, Otonomy Inc., WellSpring Pharmaceutical Corporation, Sound
Pharmaceutical, Jubilant Cadista, Auris Medical, Pfizer Inc, Sun Pharmaceutical
Industries Ltd, Novartis AG, Abbott, Bayer AG, GlaxoSmithKline plc, Amneal
Pharmaceuticals LLC., LUPIN, Sanofi, Solvay, XOMA and others.
Get full details of TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-menieres-disease-drug-market
Reasons
for Buying this Report
This report provides pin-point analysis for changing
competitive dynamics
It provides a forward looking perspective on different
factors driving or restraining market growth
It provides a six-year forecast assessed on the basis
of how the market is predicted to grow
It helps in understanding the key product segments and
their future
It provides pin point analysis of changing competition
dynamics and keeps you ahead of competitors
It helps in making informed business decisions by
having complete insights of market and by making in-depth analysis of market
segments
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-menieres-disease-drug-market
About
Us:
Data
Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting
firm with unparalleled level of resilience and integrated approaches. We are
determined to unearth the best market opportunities and foster efficient information
for your business to thrive in the market
Contact:
Tel:
+1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse
Related Reports @